Forbes on the future

How will the new administration regulate weight-loss drugs? The truth is, we don't know yet. Forbes considers the question, though, in "Which Side Will Makary Take In The Fight Over Weight Loss Drugs?" with a bit of input from APC, of course.

Related posts

Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been...

Over the last few weeks, with the FDA declaring the end of the GLP-1 shortages, APC’s reporter...

One of the better articles we've seen lately comes from USA Today, explaining what is likely to...